Interpretable AI links routine clinical gout phenotypes to multi-omic signatures and divergent health trajectories
Integrative frameworks that connect scalable clinical phenotypes with molecular mechanisms are needed to resolve disease heterogeneity. We developed and externally evaluated an interpretable gout clinical-subset framework using routine data from 21,235 participants across UK Biobank (UKB; n = 10,599), the multicentre Chinese GoutRe registry ( n = 8617), and MIMIC-IV ( n = 2019). Unsupervised learning on six prespecified routine laboratory variables identified three subsets: C1, a low-burden state with preserved reserve; C2, a urate-metabolic inflammatory state with the greatest recurrence liability and a greater cardiometabolic and hepatic comorbidity burden; and C3, a state characterized by systemic vulnerability and higher mortality. In UKB, death-competing recurrence analysis showed a higher recurrence incidence for C2 versus C1 (subdistribution hazard ratio [sHR] 1.896, 95% CI 1.710–2.101), whereas C3 did not differ from C1 (sHR 0.994, 95% CI 0.887–1.112). A six-variable CRT model reconstructed the locked subset labels using nested 10-fold out-of-fold evaluation in UKB and external application without retraining in GoutRe and MIMIC-IV. One-versus-rest AUCs were 0.965/0.945/0.980 in UKB, 0.906/0.914/0.953 in GoutRe, and 0.912/0.898/0.962 in MIMIC-IV for C1/C2/C3, respectively. Genetic, proteomic, and metabolomic analyses supported distinct urate-inflammatory and systemic-vulnerability axes, although the C3 senescence-related genetic signal was nominal and requires replication. Routine laboratory data can identify gout clinical subsets with distinct molecular profiles and patterns of recurrence and mortality; whether these subsets can guide clinical management requires prospective evaluation.
Authors
- Junqing Zhu (ORCID: https://orcid.org/0000-0003-4642-2981)
- Guichuan Lai (ORCID: https://orcid.org/0000-0002-4716-477X)
- Yongyin Li (ORCID: https://orcid.org/0000-0001-6303-7642)
- Jiani Liu (ORCID: https://orcid.org/0000-0001-5291-1103)
- Qingqing Zhang
- Qi Li (ORCID: https://orcid.org/0000-0002-9144-148X)
- Juan Li (ORCID: https://orcid.org/0000-0002-2977-2966)
- Yiwen Liao (ORCID: https://orcid.org/0000-0002-5125-2502)
- Siqi Zhang
- Shixian Chen (ORCID: https://orcid.org/0000-0002-7200-433X)
- Fei Zhong (ORCID: https://orcid.org/0009-0008-4993-9234)
- Meng Li
- Tao Wang
- Wenxia Lin
- Ruifeng Lin
- Peiying Wang
- Tianfu Pang
- Xiaoling Chen
- Han Xiong
- Mingyang Jiang
- Yuying Zhang (ORCID: https://orcid.org/0009-0000-4956-5174)
- Qingyun Li
- Peng Chen
- Hui Zhang
Institutions
- Guangxi Medical University (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- Key Laboratory of Guangdong Province (CN)
- Nanfang Hospital (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
- Guangdong Academy of Medical Sciences (CN)
- Guangdong Provincial People's Hospital (CN)
- Southern Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- npj Digital Medicine
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1038/s41746-026-03507-3
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation